Cambridge Bioscience is pleased to partner with Vector Biolabs - a leading provider of high-quality AAV and adenoviral vectors with over 20 years of expertise, and citations in more than 5,000 peer-reviewed publications. Their team of dedicated scientists understand the complexities of viral vector design and is committed to helping researchers overcome challenges in gene delivery and therapeutic development.
Cambridge Bioscience will distribute Vector Biolabs products in the UK and Ireland.
Learn more about Vector Biolabs, or contact our specialists.
Published
05 Mar 2025